TI
RUBY

Trexquant Investment’s Rubius Therapeutics, Inc RUBY Stock Holding History

Trexquant Investment’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,455
Closed -$169K – 1848
2021
Q4 		$169K Sell
17,455
-8,866
-34% -$123K 0.01% 1180
2021
Q3 		$471K Buy
26,321
+12,572
+91% +$273K 0.04% 564
2021
Q2 		$336K Buy
+13,749
New +$344K 0.03% 660
2021
Q1 		– Sell
-13,323
Closed -$101K – 1578
2020
Q4 		$101K Sell
13,323
-23,040
-63% -$137K 0.01% 967
2020
Q3 		$182K Buy
36,363
+6,721
+23% +$35.6K 0.01% 1099
2020
Q2 		$177K Buy
+29,642
New +$175K 0.01% 1065
2020
Q1 		– Sell
-27,739
Closed -$264K – 1512
2019
Q4 		$264K Buy
+27,739
New +$268K 0.02% 800

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return

Trexquant Investment's RUBY Position: Q1 2022 in Review

Trexquant Investment sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2022, closing a stake of 17,455 shares — an estimated $169K sold.

Trexquant Investment first reported a position in RUBY in Q4 2019 and held it in 7 quarters. The position peaked at $471K in Q3 2021. 117 funds tracked by Wall St. Rank hold RUBY as of Q1 2022.

  • Trexquant Investment reported no remaining Rubius Therapeutics, Inc position as of Q1 2022 after selling out during the quarter.
  • Trexquant Investment sold 17,455 Rubius Therapeutics, Inc shares in Q1 2022, an estimated $169K.
  • Trexquant Investment first reported a position in Rubius Therapeutics, Inc in Q4 2019 and held it in 7 quarters.
  • Trexquant Investment's Rubius Therapeutics, Inc position peaked at $471K in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2022.

Based on Trexquant Investment's 13F filing for Q1 2022, filed 13 May 2022.